Learn how cross-liability coverage in insurance policies enables parties to sue each other under the same contract, with ...

Zepbound, which contains the active ingredient tirzepatide, has Food and Drug Administration (FDA) approval for the following: weight management in adults with obesity weight management in adults with ...

The nonpartisan Congressional Budget Office projects that 2.9 million people who stand to lose Medicaid from President Donald Trump’s tax and spending law are already covered by Medicare or by ...

Medicaid is the single largest health insurance program in the United States. Nearly 80 million low-income children and adults, pregnant women, seniors, and people with disabilities are covered by ...

Washington — Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President Trump announced on Thursday. "Until now, neither of these ...

Original Medicare (Part A and Part B), Part D, and Medicare Advantage typically offer coverage for the osteoporosis drug Prolia. However, individuals must meet certain requirements for Part B coverage ...

Medicare covers Wegovy only as a treatment to reduce the risk of heart attacks and strokes in people who are overweight or obese. It does not cover Wegovy for weight loss. Wegovy (semaglutide) is a ...

Insurance may cover Zepbound (tirzepatide) depending on your plan and the specific condition being treated. To determine whether your plan covers Zepbound, contact your insurance provider directly. If ...